Condition: SAH (Subarachnoid Hemorrhage) · Headache · Sponsor: University of California, Davis
The study titled \"Transnasal sphenopalatine ganglion block for treatment of acute subarachnoid hemorrhage associated headache\" is a randomized controlled pilot study aimed at evaluating the efficacy of a transnasal sphenopalatine ganglion (SPG) block in addition to standard pain medication for reducing headache severity in patients with acute subarachnoid hemorrhage (aSAH). The study also examines whether this intervention can reduce opioid requirements during hospitalization and upon discharge.
This description comes directly from the study's public registry record.
Janice Wang-Polagruto, PhD, CCRP · 916-551-3244 · jfwang@ucdavis.edu
Ryan Martin, MD · 916-734-4300 · rymartin@ucdavis.edu
Always discuss trial participation with your own doctor first.
| UC Davis Medical Center | Sacramento, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06621329